AzTrials
AzTrials

Respiratory Muscle StrengthNCT06677346

Parity and Respiratory Muscle Strength in Women

An observational study of Respiratory Muscle Strength and Parity, run by Medipol University at 1 site in Turkey (Türkiye).

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

The aim of this study is to investigate the relationship between parity and respiratory muscle strength in women. Read more about this study

Who is it for?
Ages 20 to 45 years, women onlyHealthy volunteers can take part
How many people
60 participants
Where
1 siteTurkey (Türkiye)
Study dates
14 Jun 2023to Dec 2024
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 20 to 45 years
  • Women only
  • Healthy volunteers accepted
  • Adult

Study population: The participant group of the research will consist of women between the ages of 20-45 and participation will be based on volunteering.

Who may be able to join

  • Being between 20-45 years old
  • Being female

Who cannot join

  • Having a body mass index of ≥30 kg/m2
  • History of cardiovascular, neurological, pulmonary disease
  • Being receiving active cancer treatment
  • Having a history of lumbar surgery
  • History of smoking
  • Being a licensed athlete

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Turkey (Türkiye)1 site, 1 recruiting
  • Istanbul Kultur University

    Istanbul

    Recruiting

Other trials in Turkey (Türkiye)

About this study

Official title: Investigating the Relationship Between Parity and Respiratory Muscle Strength in Women.

The aim of this study is to investigate the relationship between parity and respiratory muscle strength in women.

Read the detailed description

In normal anatomical structure, there is myofascial continuity between the diaphragm, abdominal muscles and pelvic floor muscles. In addition to this anatomical unity, when the diaphragm muscle descends with inhalation, the pelvic floor muscle moves caudally, allowing breathing to encounter less resistance; the opposite occurs during exhalation.

Pregnancy and childbirth create anatomical and physiological changes in the female body. As a result of the growing uterus, the diaphragm moves upwards, while the pelvic floor muscles become depressed as intra-abdominal weight increases. On the other hand, it is thought that increased ligament laxity is responsible for changes in the body's muscle structure, especially in the lower body. Considering these pregnancy-related changes, the functions of these interrelated muscle groups may be affected and synergistic movements in the woman's body may be disrupted after pregnancy.

The aim of this study is to examine whether the anatomical structures affected during pregnancy have permanent effects on respiratory muscle strength and core muscles after birth. Volunteers who agree to participate in the study will be divided into groups according to their birth counts and respiratory and core muscles will be evaluated using objective methods.

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT06677346
Study groupRoleWhat they receive
NulliparousWomen who have never given birth
PrimiparousWomen who have given birth once
MultiparousWomen who have given birth multiple times

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Respiratory Muscle Strength/ maximal inspiratory pressure (MIP)

    Participants' maximal inspiratory pressure (MIP) measurements will be evaluated using the COSMED Pony FX spirometry device according to American Thoracic Society/European Respiratory Society standards.

    Measured: On the day of enrollment

  2. Respiratory Muscle Strength/maximal expiratory pressure (MEP)

    Participants' maximal expiratory pressure (MEP) measurements will be evaluated using the COSMED Pony FX spirometry device according to American Thoracic Society/European Respiratory Society standards.

    Measured: On the day of enrollment

Secondary outcomes (3)
  1. Pressure Biofeedback Unite

    Core muscle stabilization will be measured with The Stabilizer Pressure Biofeedback Unit. Individuals are asked to lie down in the supine and prone positions. After the pressure cell of the instrument is placed with reference to the Anterior superior iliac spines (ASIS) and Posterior superior iliac spines (PSIS), the subjects are asked to perform a drawing-in maneuver. The contraction that can be sustained for 10 seconds is recorded in mmHg.

    Measured: On the day of enrollment

  2. Trunk Muscle Endurance Tests

    The endurance of the trunk flexor, trunk extensor and lateral flexor muscles is evaluated by recording the maximum time that the person can maintain the test position.

    Measured: On the day of enrollment

  3. Physical Activity Level

    Individuals' physical activity levels will be questioned with the International Physical Activity Questionnaire (IPAQ) Short Form. It is a 7-item scale. Physical activity levels are classified into 3 categories according to the scores obtained by multiplying the duration, frequency and MET values of the physical activities that the participants participated in within 7 days and for at least 10 minutes. Accordingly, <600 MET - min/week is defined as inactive, 600 - 3000 MET - min/week low, and >3000 MET - min/week is defined as sufficient physical activity level.

    Measured: On the day of enrollment

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted6 Nov 2024
  2. Study start14 Jun 2023
  3. Primary completionDec 2024 (estimated)
  4. Study completionDec 2024 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Cross-sectional
Enrolment
60 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06677346
Sponsor's protocol ID
İK-2023-02
Status last verified
Nov 2024
First submitted
4 Nov 2024
Last updated
6 Nov 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Respiratory Muscle Strength and Parity, run by Medipol University at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 6 Nov 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Imge NAS (+902124984141, i.nas@iku.edu.tr), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Respiratory Muscle Strength/ maximal inspiratory pressure (MIP) (time frame: On the day of enrollment). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 Nov 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in